GlobeNewswire Inc.··Not SpecifiedFDA Accepts Teva's Application for Monthly Olanzapine Injection to Treat Schizophrenia
FDA accepts Teva's application for monthly olanzapine injection treating schizophrenia. The formulation eliminates post-injection monitoring requirements while maintaining efficacy.
TEVAFDA approvalschizophrenia treatment